NCT06076629

Brief Summary

This is a randomized controlled human exposure crossover study. Investigators aims to assess the acute effects of low temperature exposure and the underlying mechanisms.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 8, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

October 10, 2023

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 11, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2023

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

October 11, 2023

Status Verified

October 1, 2023

Enrollment Period

1 month

First QC Date

September 8, 2023

Last Update Submit

October 3, 2023

Conditions

Keywords

Low temperatureRandomized controlled trialCardiopulmonary effectsCognitive function

Outcome Measures

Primary Outcomes (6)

  • Heart Rate Variability Parameters

    Investigators plan to measure heart rate variability (HRV) parameters (e.g., SDNN, PNN50, LF, HF)

    Volunteers will be asked to wear electrographic Holter monitors for 24 hours from 1:00 P.M. at the day of intervention to 1:00 P.M. at the next day.

  • Blood Pressure

    The changes of systolic blood pressure (SBP) and diastolic blood pressure (DBP) will be measured.

    Blood pressure will be examined before exposure and immediately after the exposure session

  • Forced vital capacity

    Investigators plan to measure forced vital capacity (FVC) by spirometry

    Lung function will be examined before exposure and half an hour after the exposure session

  • Forced expiratory volume in one second

    Investigators plan to measure forced expiratory volume in one second (FEV1) by spirometry.

    Lung function will be examined before exposure and half an hour after the exposure session

  • Maximal mid-expiratory flow

    Investigators plan to measure maximal mid-expiratory flow (MMEF) by spirometry.

    Lung function will be examined before exposure and half an hour after the exposure session

  • Results of Stroop Tests

    Investigators plan to measure the changes of cognitive function using Stroop Test.

    The tests will be conducted before exposure and immediately after the exposure session

Secondary Outcomes (5)

  • Changes of skin temperature

    Skin temperature will be examined from 1:00 P.M. to 4:30 P.M. at the day of intervention

  • Results of simple reaction time

    Simple reaction time will be examined before exposure and immediately after the exposure session

  • Results of visual memory

    Visual memory will be examined before exposure and immediately after the exposure session

  • Activated brain regions demonstrating brain activity related to the low temperature exposure

    MRI will be examined 1 hour after the exposure session

  • Changes in cerebral hemodynamics demonstrating brain activity related to the low temperature exposure

    fNIRS will be examined before exposure and immediately after the exposure session

Other Outcomes (7)

  • Differences in metabolites detected in blood between the two exposures

    Blood will be collected 1 hour after the exposure session

  • Differences in protein levels detected in blood between the two exposures

    Blood will be collected 1 hour after the exposure session

  • Differences in DNA methylation levels detected in whole-blood between the two exposures

    Blood will be collected 1 hour after the exposure session

  • +4 more other outcomes

Study Arms (2)

Low temperature (16#) group

EXPERIMENTAL

Subjects in exposure group will be exposed to low temperature (16#) for about 2 hours in a chamber.

Other: Low temperature (16#) group

Moderate temperature (22#) group

SHAM COMPARATOR

Subjects in exposure group will be exposed to moderate temperature (22#) for about 2 hours in a chamber.

Other: Moderate temperature (22#) group

Interventions

The exposure group will be exposed to low temperature (16#) in a chamber for about 2 hours, resting during the whole periods.

Low temperature (16#) group

The exposure group will be exposed to thermoneutral temperature (22#) in a chamber for about 2 hours, resting during the whole periods.

Moderate temperature (22#) group

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Living in Shanghai during the study period;
  • Body mass index \> 18.5 and ≤ 28;
  • Right-handed;
  • Receiving or having received higher education;
  • With the ability to read and understand Chinese smoothly.

You may not qualify if:

  • Smoking and alcohol abuse;
  • Current drug and dietary supplements intake;
  • Subjects with allergic diseases, such as allergic rhinitis, allergic asthma, and atopy;
  • Subjects with cardiovascular diseases, such as congenital heart disease, pulmonary heart disease, and hypertension;
  • Subjects with respiratory diseases, such as asthma, chronic bronchitis, and chronic obstructive pulmonary disease;
  • Subjects with chronic diseases, such as diabetes, chronic hepatitis, and kidney disease;
  • Subjects who have a history of major surgery due to cardiovascular, cerebrovascular, respiratory, or neurological diseases;
  • Subjects with neurologic disorders, such as stroke, traumatic brain injury, epilepsy, and schizophrenia;
  • Abnormal spirometry (FEV1 and FVC ≤ 75% of predicted and FEV1/FVC ≤ 0.65);
  • Subjects with color vision disabilities.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Environmental Health, School of Public Health, Fudan University

Shanghai, Shanghai Municipality, 200032, China

Location

MeSH Terms

Interventions

Cold TemperaturePopulation Groups

Intervention Hierarchy (Ancestors)

TemperatureThermodynamicsPhysical PhenomenaWeatherAtmosphereEnvironmentEcological and Environmental PhenomenaBiological PhenomenaMeteorological ConceptsEnvironment and Public HealthDemographyPopulation Characteristics

Study Officials

  • Haidong Kan, PhD

    Department of Environmental Health, School of Public Health, Fudan University

    STUDY DIRECTOR

Central Study Contacts

Haidong Kan, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 8, 2023

First Posted

October 11, 2023

Study Start

October 10, 2023

Primary Completion

November 15, 2023

Study Completion

December 31, 2024

Last Updated

October 11, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations